3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
2
Completed
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Lymphoid
7
Thoracic
2
Myeloid
2
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Myelodysplastic Syndromes
750
Leukemia, Myeloid, Acute
635
Leukemia
476
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
470
Precursor Cell Lymphoblastic Leukemia-Lymphoma
409
Myeloproliferative Disorders
339
Lymphoma, Non-Hodgkin
271
Leukemia, Myelomonocytic, Chronic
270
Leukemia, Lymphocytic, Chronic, B-Cell
264
Multiple Myeloma
259
Hodgkin Disease
249
Primary Myelofibrosis
230
Leukemia, Myeloid, Chronic-Phase
217
Lymphoma
203
Blast Crisis
195
Leukemia, Myeloid, Accelerated Phase
182
Lymphoma, Mantle-Cell
168
Lymphoma, Follicular
168
Burkitt Lymphoma
166
Lymphoma, Large B-Cell, Diffuse
162
Lymphoma, B-Cell, Marginal Zone
151
Congenital Abnormalities
148
Polycythemia Vera
144
Lymphoma, Large-Cell, Immunoblastic
141
Anemia, Refractory, with Excess of Blasts
131
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
128
Myelodysplastic-Myeloproliferative Diseases
126
Neoplasms, Plasma Cell
117
Thrombocythemia, Essential
114
Lymphoma, T-Cell, Cutaneous
99
Interventions
masitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Pruritus
×
Myeloid
×
Clear all
NCT04018209
2024-11-01
PANAM
University Hospital, Brest
Completed
170 enrolled
NCT00814073
2019-12-03
AB06006
AB Science
Phase 3
Completed
135 enrolled